Location History:
- Bothell, WA (US) (2002)
- Seattle, WA (US) (2003 - 2023)
Company Filing History:
Years Active: 2002-2023
Title: Innovations and Contributions of Kenneth M Ferguson
Introduction
Kenneth M Ferguson is a notable inventor based in Seattle, WA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations and inhibitors. With a total of 5 patents to his name, Ferguson's work has the potential to impact therapeutic methods significantly.
Latest Patents
Ferguson's latest patents include groundbreaking inventions such as highly concentrated low viscosity MASP-2 inhibitory antibody formulations. This invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, along with kits and therapeutic methods for inhibiting the adverse effects of MASP-2 dependent complement activation. Another notable patent is for an optically active PDE10 inhibitor, which focuses on a pure enantiomer of a specific compound. This invention also includes a crystal structure of the compound, a pharmaceutical composition, and methods for inhibiting PDE10.
Career Highlights
Throughout his career, Kenneth M Ferguson has worked with prominent companies such as Omeros Corporation and Lilly Icos LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the pharmaceutical industry.
Collaborations
Ferguson has collaborated with notable individuals in his field, including Neil S Cutshall and Charles Prince Zuta. These collaborations have likely enriched his work and expanded the scope of his inventions.
Conclusion
Kenneth M Ferguson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to advancing therapeutic methods. His work continues to pave the way for future developments in the industry.